Researchers are studying a valuable target in regulating the immune response in cancer and autoimmunity. VISTA is a tempering molecule that hinders T cells in the immune system from activating against self-antigens such as cancer cells. Their new publication describes how VISTA controls T-cell responses.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/01/200116141724.htm
No comments:
Post a Comment